首页 > 最新文献

Actas urologicas espanolas最新文献

英文 中文
Urinary diversion and quality of life: A six-year follow-up study of bladder cancer surgery.
Pub Date : 2025-02-11 DOI: 10.1016/j.acuroe.2025.501699
N Pyrgidis, J Hermans, P Keller, D Karatas, B Ebner, G Schulz, C Stief, Y Volz

Objectives: To evaluate health-related quality of life (HRQOL) six years post-radical cystectomy in patients with muscle-invasive bladder cancer, comparing orthotopic ileal neobladder (ONB) and ileal conduit (IC). Therefore, the study aims to analyze the under-investigated long-term impact of standard bladder cancer treatments on HRQOL and provide insights into the HRQOL differences associated with these two common urinary diversion methods.

Patients and methods: This prospective study included 39 patients with urothelial carcinoma treated with ONB or IC at our center between 03/2013 and 01/2023. Patients with variant histology, metastasis, neoadjuvant chemotherapy, or benign indications for cystectomy were excluded. HRQOL was assessed using the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire preoperatively, at four and six years postoperatively. Statistical analyses included Chi-square tests, T-tests, and logistic regression models.

Results: Of the patients, 64% (25/39) underwent ONB, and 76.9% (30/39) were male, with an average age of 69 years. No significant differences in overall good HRQOL (GHS > 70) were observed between ONB and IC at six years (IC: 60 ± 22; ONB: 69 ± 23, p = 0.2). Patients with IC reported higher insomnia at both follow-ups (4 years: p = 0.01; 6 years: p = 0.03). Emotional function remained stable in ONB patients but declined in IC patients from the fourth to sixth years (p = 0.04).

Conclusion: Long-term HRQOL did not significantly differ between ONB and IC up to six years post-radical cystectomy. Both urinary diversion methods can be offered to patients, with tailored discussions in terms of HRQOL.

{"title":"Urinary diversion and quality of life: A six-year follow-up study of bladder cancer surgery.","authors":"N Pyrgidis, J Hermans, P Keller, D Karatas, B Ebner, G Schulz, C Stief, Y Volz","doi":"10.1016/j.acuroe.2025.501699","DOIUrl":"10.1016/j.acuroe.2025.501699","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate health-related quality of life (HRQOL) six years post-radical cystectomy in patients with muscle-invasive bladder cancer, comparing orthotopic ileal neobladder (ONB) and ileal conduit (IC). Therefore, the study aims to analyze the under-investigated long-term impact of standard bladder cancer treatments on HRQOL and provide insights into the HRQOL differences associated with these two common urinary diversion methods.</p><p><strong>Patients and methods: </strong>This prospective study included 39 patients with urothelial carcinoma treated with ONB or IC at our center between 03/2013 and 01/2023. Patients with variant histology, metastasis, neoadjuvant chemotherapy, or benign indications for cystectomy were excluded. HRQOL was assessed using the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire preoperatively, at four and six years postoperatively. Statistical analyses included Chi-square tests, T-tests, and logistic regression models.</p><p><strong>Results: </strong>Of the patients, 64% (25/39) underwent ONB, and 76.9% (30/39) were male, with an average age of 69 years. No significant differences in overall good HRQOL (GHS > 70) were observed between ONB and IC at six years (IC: 60 ± 22; ONB: 69 ± 23, p = 0.2). Patients with IC reported higher insomnia at both follow-ups (4 years: p = 0.01; 6 years: p = 0.03). Emotional function remained stable in ONB patients but declined in IC patients from the fourth to sixth years (p = 0.04).</p><p><strong>Conclusion: </strong>Long-term HRQOL did not significantly differ between ONB and IC up to six years post-radical cystectomy. Both urinary diversion methods can be offered to patients, with tailored discussions in terms of HRQOL.</p>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":" ","pages":"501699"},"PeriodicalIF":0.0,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143416406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mixed epithelial and stromal kidney tumor with sarcomatous transformation. A case report.
Pub Date : 2025-02-11 DOI: 10.1016/j.acuroe.2025.501692
A C Jiménez Domínguez, A J G Álvarez Lucena, P Vila Braña, F Vázquez Alonso
{"title":"Mixed epithelial and stromal kidney tumor with sarcomatous transformation. A case report.","authors":"A C Jiménez Domínguez, A J G Álvarez Lucena, P Vila Braña, F Vázquez Alonso","doi":"10.1016/j.acuroe.2025.501692","DOIUrl":"10.1016/j.acuroe.2025.501692","url":null,"abstract":"","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":" ","pages":"501692"},"PeriodicalIF":0.0,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143416391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-port retroperitoneal adrenalectomy: The current approach.
Pub Date : 2025-02-10 DOI: 10.1016/j.acuroe.2025.501694
D Vazquez-Martul
{"title":"Single-port retroperitoneal adrenalectomy: The current approach.","authors":"D Vazquez-Martul","doi":"10.1016/j.acuroe.2025.501694","DOIUrl":"10.1016/j.acuroe.2025.501694","url":null,"abstract":"","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":" ","pages":"501694"},"PeriodicalIF":0.0,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143412150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mastering the curve: Advances and challenges in teaching endoscopic enucleation of the prostate.
Pub Date : 2025-02-10 DOI: 10.1016/j.acuroe.2025.501695
I Schwartzmann
{"title":"Mastering the curve: Advances and challenges in teaching endoscopic enucleation of the prostate.","authors":"I Schwartzmann","doi":"10.1016/j.acuroe.2025.501695","DOIUrl":"10.1016/j.acuroe.2025.501695","url":null,"abstract":"","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":" ","pages":"501695"},"PeriodicalIF":0.0,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143412140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of preoperative-guided pelvic floor exercises on urinary incontinence and quality of life after robotic radical prostatectomy.
Pub Date : 2025-02-10 DOI: 10.1016/j.acuroe.2025.501702
C García-Sánchez, I García Obrero, C Muñoz-Calahorro, A J Rodríguez-Pérez, R A Medina-López

Introduction and objective: Radical prostatectomy has a great impact on urinary continence, although it is a multifactorial aspect. The aim of the study was to evaluate the effect of guided Pelvic Floor Exercises (PFE) versus written information prior to robotic radical prostatectomy (RRP) on the rate of urinary incontinence, and their effect on patients' quality of life.

Material and method: 62 patients were randomized to an experimental (physiotherapist-guided exercises) or control (written information) group. The primary outcome was incontinence rate (measured by pad test). Secondary outcomes were incontinence severity, quality of life (measured by the 36-Item Short Form Survey Instrument (SF-36) and the King's Health Questionnaire (KHQ)), voiding dynamics, correlation between incontinence and quality of life, and other incontinence-related factors.

Results: We found no differences in the incontinence rate between groups in the months of follow-up (82.61% vs. 84.62%, month 1; 61.54% vs. 75.86%, month 3; 50% vs. 53.33%, month 6; 30.77% vs. 40%, month 12) nor in the severity of incontinence between groups. There were significant differences in the quality of life related to "emotional problems" and "personal relationships", in favor of the control group. We found correlations between incontinence severity and age, severity and quality of life, urgency/frequency and quality of life.

Conclusions: Guided exercises prior to RRP do not seem to offer benefits over written information in either the rate or severity of incontinence. Urinary incontinence correlates with age and quality of life. Quality of life correlates with urgency and voiding frequency.

{"title":"Efficacy of preoperative-guided pelvic floor exercises on urinary incontinence and quality of life after robotic radical prostatectomy.","authors":"C García-Sánchez, I García Obrero, C Muñoz-Calahorro, A J Rodríguez-Pérez, R A Medina-López","doi":"10.1016/j.acuroe.2025.501702","DOIUrl":"10.1016/j.acuroe.2025.501702","url":null,"abstract":"<p><strong>Introduction and objective: </strong>Radical prostatectomy has a great impact on urinary continence, although it is a multifactorial aspect. The aim of the study was to evaluate the effect of guided Pelvic Floor Exercises (PFE) versus written information prior to robotic radical prostatectomy (RRP) on the rate of urinary incontinence, and their effect on patients' quality of life.</p><p><strong>Material and method: </strong>62 patients were randomized to an experimental (physiotherapist-guided exercises) or control (written information) group. The primary outcome was incontinence rate (measured by pad test). Secondary outcomes were incontinence severity, quality of life (measured by the 36-Item Short Form Survey Instrument (SF-36) and the King's Health Questionnaire (KHQ)), voiding dynamics, correlation between incontinence and quality of life, and other incontinence-related factors.</p><p><strong>Results: </strong>We found no differences in the incontinence rate between groups in the months of follow-up (82.61% vs. 84.62%, month 1; 61.54% vs. 75.86%, month 3; 50% vs. 53.33%, month 6; 30.77% vs. 40%, month 12) nor in the severity of incontinence between groups. There were significant differences in the quality of life related to \"emotional problems\" and \"personal relationships\", in favor of the control group. We found correlations between incontinence severity and age, severity and quality of life, urgency/frequency and quality of life.</p><p><strong>Conclusions: </strong>Guided exercises prior to RRP do not seem to offer benefits over written information in either the rate or severity of incontinence. Urinary incontinence correlates with age and quality of life. Quality of life correlates with urgency and voiding frequency.</p>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":" ","pages":"501702"},"PeriodicalIF":0.0,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143412135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical prostate cancer recurrence in the vas deferens detected by [18F]F-piflufolastat PET/CT imaging. 通过 [18F]F-piflufolastat PET/CT 成像检测输精管内的非典型前列腺癌复发。
Pub Date : 2025-02-10 DOI: 10.1016/j.acuroe.2025.501690
S Bondia-Bescós, J J Martín-Marcuartu, J J Robles-Barba, M Cortés-Romera
{"title":"Atypical prostate cancer recurrence in the vas deferens detected by [<sup>18</sup>F]F-piflufolastat PET/CT imaging.","authors":"S Bondia-Bescós, J J Martín-Marcuartu, J J Robles-Barba, M Cortés-Romera","doi":"10.1016/j.acuroe.2025.501690","DOIUrl":"10.1016/j.acuroe.2025.501690","url":null,"abstract":"","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":" ","pages":"501690"},"PeriodicalIF":0.0,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143412134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective analysis of the learning curve in holmium laser enucleation of the prostate (HoLEP): A 125 case series.
Pub Date : 2025-02-10 DOI: 10.1016/j.acuroe.2025.501705
L E Ortega Polledo, E García Rico, A Sánchez Pellejero, G F J Bianchini Hernández, A Sanchís Bonet, J Gómez Rivas, I Galante Romo, J Moreno Sierra, B Miñana, S Ahyai, S Alonso Y Gregorio

Objective: The objective is to evaluate the effectiveness and safety of a surgeon's learning curve for holmium laser enucleation of the prostate (HoLEP) in 125 consecutive cases.

Materials and methods: Preoperative baseline characteristics, functional outcomes, surgical times, and complications of the first 125 patients treated by HoLEP were recorded. The sample was divided into quintiles (25 cases/group), and statistical analysis was carried out using the ANOVA test, Kruskal-Wallis H test, Chi-squared test, and likelihood-ratio test.

Results: Surgical time decreased progressively: 92 min. (Q1), 65 min. (Q2), 54 min. (Q3), 45 min. (Q4) and 50 min. (Q5) (p < 0.001). Enucleation rate gradually increased: 1.08 g/min (Q1), 1.65 g/min (Q2), 1.82 g/min (Q3), 1.96 g/min (Q4) and 2.74 g/min (Q5) (p < 0.001). There were no differences in enucleated weight (Q1: 51 g, Q2: 57 g, Q3: 51 g, Q4: 53 g, Q5: 65 g) (p = 0.21), length of hospital stay (median 1.12 days), bladder catheterization (mean 1.51 days), intra- and postoperative complications or urethral stricture (5.6%) (p > 0.05). Time to continence recovery was similar in quintiles 1-4 (23, 27, 21, 20 days) and shorter in quintile 5 (3.5 days) (p < 0.001).

Conclusion: The initiation of a HoLEP program following the completion of training demonstrates a low morbidity rate and highly favorable functional outcomes. The efficiency of the technique demonstrates a linear and consistent increase from the outset of the learning curve, with significantly reduced surgical times achieved after 25 cases.

{"title":"Prospective analysis of the learning curve in holmium laser enucleation of the prostate (HoLEP): A 125 case series.","authors":"L E Ortega Polledo, E García Rico, A Sánchez Pellejero, G F J Bianchini Hernández, A Sanchís Bonet, J Gómez Rivas, I Galante Romo, J Moreno Sierra, B Miñana, S Ahyai, S Alonso Y Gregorio","doi":"10.1016/j.acuroe.2025.501705","DOIUrl":"10.1016/j.acuroe.2025.501705","url":null,"abstract":"<p><strong>Objective: </strong>The objective is to evaluate the effectiveness and safety of a surgeon's learning curve for holmium laser enucleation of the prostate (HoLEP) in 125 consecutive cases.</p><p><strong>Materials and methods: </strong>Preoperative baseline characteristics, functional outcomes, surgical times, and complications of the first 125 patients treated by HoLEP were recorded. The sample was divided into quintiles (25 cases/group), and statistical analysis was carried out using the ANOVA test, Kruskal-Wallis H test, Chi-squared test, and likelihood-ratio test.</p><p><strong>Results: </strong>Surgical time decreased progressively: 92 min. (Q1), 65 min. (Q2), 54 min. (Q3), 45 min. (Q4) and 50 min. (Q5) (p < 0.001). Enucleation rate gradually increased: 1.08 g/min (Q1), 1.65 g/min (Q2), 1.82 g/min (Q3), 1.96 g/min (Q4) and 2.74 g/min (Q5) (p < 0.001). There were no differences in enucleated weight (Q1: 51 g, Q2: 57 g, Q3: 51 g, Q4: 53 g, Q5: 65 g) (p = 0.21), length of hospital stay (median 1.12 days), bladder catheterization (mean 1.51 days), intra- and postoperative complications or urethral stricture (5.6%) (p > 0.05). Time to continence recovery was similar in quintiles 1-4 (23, 27, 21, 20 days) and shorter in quintile 5 (3.5 days) (p < 0.001).</p><p><strong>Conclusion: </strong>The initiation of a HoLEP program following the completion of training demonstrates a low morbidity rate and highly favorable functional outcomes. The efficiency of the technique demonstrates a linear and consistent increase from the outset of the learning curve, with significantly reduced surgical times achieved after 25 cases.</p>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":" ","pages":"501705"},"PeriodicalIF":0.0,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143412148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NSAIDs: An alternative to antibiotics for infections urinary in women? - An evidence-based review. 非甾体抗炎药:非甾体抗炎药:治疗女性泌尿系统感染的抗生素替代品?- 循证审查。
Pub Date : 2025-02-10 DOI: 10.1016/j.acuroe.2025.501684
I Milhazes Martins, S C Dias Batista

Introduction: Urinary tract infections (UTIs) remain a major cause of morbidity in otherwise healthy women. It is estimated at least 50% of women will have at least 1 UTI in their lifetime. Current guidelines recommend the use of antibiotics (ABs) for treatment, constituting the 2nd most common reason for their prescribing. However, antibiotic resistance remains a worrying problem, therefore it is almost imperative to find alternatives for UTIs. One of the most suggested alternatives are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Some clinical trials have shown that these are similar to ABs in resolving urinary symptoms OBJETIVOS: evaluar la eficacia de los AINE en el tratamiento de las ITU no complicadas en mujeres sanas no embarazadas, y demostrar su no inferioridad frente al tratamiento antibiótico. MéTODOS: Esta revisión basada en la evidencia incluyó artículos publicados entre enero de 2010 y diciembre de 2021 en bases de datos médicas, utilizando las palabras clave MeSH: «NSAIDs», «UTI» y «Treatment». Se utilizó la escala Strength of Recommendation Taxonomy (SORT) para clasificar el nivel de la evidencia.

Resultados: De los 8 artículos seleccionados, la mayoría concluyeron que los AB son más eficaces para el tratamiento de las ITU, ya que el cuadro clínico se resolvió con mayor rapidez. Sin embargo, según los artículos, los AINE también demostraron ser eficaces. Por otra parte, se encontró que el tratamiento con AINE no presenta un riesgo mayor de complicaciones.

Conclusiones: Los AB siguen siendo el tratamiento de elección para las ITU, y aún no hay datos suficientes que apoyen el uso de AINE. Sin embargo, se necesitan más estudios para evaluar su eficacia en el manejo de los síntomas de las ITU, pues podrían suponer una alternativa para reducir la prescripción de AB.

{"title":"NSAIDs: An alternative to antibiotics for infections urinary in women? - An evidence-based review.","authors":"I Milhazes Martins, S C Dias Batista","doi":"10.1016/j.acuroe.2025.501684","DOIUrl":"10.1016/j.acuroe.2025.501684","url":null,"abstract":"<p><strong>Introduction: </strong>Urinary tract infections (UTIs) remain a major cause of morbidity in otherwise healthy women. It is estimated at least 50% of women will have at least 1 UTI in their lifetime. Current guidelines recommend the use of antibiotics (ABs) for treatment, constituting the 2nd most common reason for their prescribing. However, antibiotic resistance remains a worrying problem, therefore it is almost imperative to find alternatives for UTIs. One of the most suggested alternatives are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Some clinical trials have shown that these are similar to ABs in resolving urinary symptoms OBJETIVOS: evaluar la eficacia de los AINE en el tratamiento de las ITU no complicadas en mujeres sanas no embarazadas, y demostrar su no inferioridad frente al tratamiento antibiótico. MéTODOS: Esta revisión basada en la evidencia incluyó artículos publicados entre enero de 2010 y diciembre de 2021 en bases de datos médicas, utilizando las palabras clave MeSH: «NSAIDs», «UTI» y «Treatment». Se utilizó la escala Strength of Recommendation Taxonomy (SORT) para clasificar el nivel de la evidencia.</p><p><strong>Resultados: </strong>De los 8 artículos seleccionados, la mayoría concluyeron que los AB son más eficaces para el tratamiento de las ITU, ya que el cuadro clínico se resolvió con mayor rapidez. Sin embargo, según los artículos, los AINE también demostraron ser eficaces. Por otra parte, se encontró que el tratamiento con AINE no presenta un riesgo mayor de complicaciones.</p><p><strong>Conclusiones: </strong>Los AB siguen siendo el tratamiento de elección para las ITU, y aún no hay datos suficientes que apoyen el uso de AINE. Sin embargo, se necesitan más estudios para evaluar su eficacia en el manejo de los síntomas de las ITU, pues podrían suponer una alternativa para reducir la prescripción de AB.</p>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":" ","pages":"501684"},"PeriodicalIF":0.0,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143412141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of robotic surgery for the management of urethral strictures and bladder neck contractures: A systematic review 机器人手术在尿道狭窄和膀胱颈挛缩治疗中的应用:系统综述。
Pub Date : 2025-01-01 DOI: 10.1016/j.acuroe.2024.11.006
G. Mantica , F. Chierigo , Ł. Białek , F.X. Madec , M. Frankiewicz , W. Verla , E.J. Redmond , C.M. Rosenbaum , A. Cocci , F. Campos-Juanatey , M. Oszczudłowski , J. Adamowicz , C. Terrone , M.W. Vetterlein , en representación del Grupo de Trabajo de Urología Reconstructiva y Trauma Urológico de la Sección de Jóvenes Urólogos Académicos - Asociación Europea de Urología

Objective

The aim of this systematic review is to offer a comprehensive view of the current use of robotic surgery for the treatment of urethral strictures and bladder neck contractures.

Methods

A systematic review of the current literature was conducted through the Medline and NCBI PubMed, Embase databases in December 2023. Keywords used were “robotic” and “robotic-assisted” combined with “urethroplasty”, “urethral stricture”, and “bladder neck contracture”. All papers published after 2000, concerning studies conducted on humans for urethral strictures and bladder neck contractures managed with robotic surgery were considered for the review. Only procedures involving a direct approach to urethra/bladder neck and/or graft harvesting for urethroplasty have been included.

Results

A total of 275 articles were evaluated after the strategy search and only 11 articles were considered eligible for the final analysis. The studies included a series of between a minimum of 1 and a maximum of 104 patients, for a total of 203 patients. The robotic surgery was performed mainly for the treatment of bladder neck contracture and posterior urethra. In some reports, the robotic system was used for graft harvesting, subsequently used with an open perineal technique. The follow-up presented in the different studies is very heterogeneous. However, most studies have high success rates, with recurrence and redo surgery rates generally below 20%. Likewise, post-procedure incontinence rates are low.

Conclusions

The outcomes presented in the literature, combined with the minimally invasive nature, suggest a possible growing role for robotic surgery in the coming years in the treatment of these diseases.
目的:本系统综述的目的是提供一个全面的观点,目前使用机器人手术治疗尿道狭窄和膀胱颈挛缩。方法:于2023年12月通过Medline和NCBI PubMed, Embase数据库对当前文献进行系统综述。关键词:“机器人”、“机器人辅助”联合“尿道成形术”、“尿道狭窄”、“膀胱颈挛缩”。所有2000年以后发表的关于机器人手术治疗人类尿道狭窄和膀胱颈挛缩的研究的论文都被纳入综述。仅包括直接入路尿道/膀胱颈和/或尿道成形术的移植手术。结果:策略检索后共评估了275篇文章,只有11篇文章被认为符合最终分析的条件。这些研究包括一系列最少1例到最多104例患者,总共203例患者。机器人手术主要用于治疗膀胱颈挛缩和后尿道。在一些报道中,机器人系统被用于移植收获,随后与开放会阴技术一起使用。在不同的研究中提出的随访是非常不同的。然而,大多数研究都有很高的成功率,复发率和重做手术率通常低于20%。同样,术后尿失禁率也很低。结论:文献中提出的结果,结合微创性,表明机器人手术在未来几年治疗这些疾病中的作用可能越来越大。
{"title":"The use of robotic surgery for the management of urethral strictures and bladder neck contractures: A systematic review","authors":"G. Mantica ,&nbsp;F. Chierigo ,&nbsp;Ł. Białek ,&nbsp;F.X. Madec ,&nbsp;M. Frankiewicz ,&nbsp;W. Verla ,&nbsp;E.J. Redmond ,&nbsp;C.M. Rosenbaum ,&nbsp;A. Cocci ,&nbsp;F. Campos-Juanatey ,&nbsp;M. Oszczudłowski ,&nbsp;J. Adamowicz ,&nbsp;C. Terrone ,&nbsp;M.W. Vetterlein ,&nbsp;en representación del Grupo de Trabajo de Urología Reconstructiva y Trauma Urológico de la Sección de Jóvenes Urólogos Académicos - Asociación Europea de Urología","doi":"10.1016/j.acuroe.2024.11.006","DOIUrl":"10.1016/j.acuroe.2024.11.006","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this systematic review is to offer a comprehensive view of the current use of robotic surgery for the treatment of urethral strictures and bladder neck contractures.</div></div><div><h3>Methods</h3><div>A systematic review of the current literature was conducted through the Medline and NCBI PubMed, Embase databases in December 2023. Keywords used were “robotic” and “robotic-assisted” combined with “urethroplasty”, “urethral stricture”, and “bladder neck contracture”. All papers published after 2000, concerning studies conducted on humans for urethral strictures and bladder neck contractures managed with robotic surgery were considered for the review. Only procedures involving a direct approach to urethra/bladder neck and/or graft harvesting for urethroplasty have been included.</div></div><div><h3>Results</h3><div>A total of 275 articles were evaluated after the strategy search and only 11 articles were considered eligible for the final analysis. The studies included a series of between a minimum of 1 and a maximum of 104 patients, for a total of 203 patients. The robotic surgery was performed mainly for the treatment of bladder neck contracture and posterior urethra. In some reports, the robotic system was used for graft harvesting, subsequently used with an open perineal technique. The follow-up presented in the different studies is very heterogeneous. However, most studies have high success rates, with recurrence and redo surgery rates generally below 20%. Likewise, post-procedure incontinence rates are low.</div></div><div><h3>Conclusions</h3><div>The outcomes presented in the literature, combined with the minimally invasive nature, suggest a possible growing role for robotic surgery in the coming years in the treatment of these diseases.</div></div>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":"49 1","pages":"Pages 11-19"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of Optilume® paclitaxel-coated urethral dilatation balloon in real-life: experience in a Spanish multicenter study Optilume® 紫杉醇涂层尿道扩张球囊在现实生活中的有效性和安全性:西班牙多中心研究的经验。
Pub Date : 2025-01-01 DOI: 10.1016/j.acuroe.2024.10.003
C. Ballesteros Ruiz , F. Campos-Juanatey , I. Povo Martín , S. Mitjana Biosca , Ó. Gorría Cardesa , J.F. Aguilar Guevara , N. García Formoso , E. Fernández Pascual , J.I. Martínez Salamanca , S. Martínez Pérez , J.M. Alonso Dorrego , E. Ríos González , S. San Cayetano Talegón , A.M. Araujo Suarez , E. Moran Pascual , M.Á. Bonillo García , J. Medina Polo , L. Viver Clotet , A.J. Vicens Morton , J. Arce Gil , L. Martínez-Piñeiro Lorenzo

Introduction

The Optilume® Paclitaxel-coated urethral dilatation balloon is an alternative to conventional endoscopic treatments that combines mechanical dilatation with local delivery of paclitaxel.

Objective

To describe the success rate and analyze the safety of the device in real clinical practice. To evaluate possible predictors of treatment failure.

Materials and methods

Retrospective multicenter study in patients diagnosed with urethral stricture and treated with an Optilume® balloon in routine clinical practice. Data were collected from flowmetry, questionnaires (PROM and IPSS) and cystoscopy before surgery, and 3, 6 and 12 months after the procedure, according to standard practice. Surgical success was defined as the absence of subsequent urethral manipulation and a Qmax >10 ml/s.

Results

238 patients treated with Optilume® in 12 Spanish hospitals between May 2021 and April 2024 were included in the study. Of these, 156 who had a minimum follow-up of 3 months, were analyzed. Median stricture length: 1.5 cm (0.5–5.3), mainly in bulbar urethra (87.7%). Of the total, 12.8% of patients had a history of pelvic radiotherapy, and 81.4% had undergone prior urethral manipulation. Postoperative complications were reported in 14.2% of the total. The treatment success rate was 73.8%, with a median follow-up of 8 months (5–12). No predictors of stricture recurrence were identified. Recurrence rates were higher in strictures located in the posterior versus anterior urethra (42.9% vs. 24.6%, p = 0.126). No significant differences were observed between patients with and without prior urethral manipulation.

Conclusion

Treatment with Optilume® has been shown to be safe and effective in short-term routine clinical practice.
简介:Optilume® 紫杉醇涂层尿道扩张球囊是传统内窥镜治疗的替代方法,它将机械扩张与紫杉醇局部给药相结合:描述该设备在实际临床实践中的成功率并分析其安全性。评估治疗失败的可能预测因素:回顾性多中心研究,对象是在常规临床实践中被诊断为尿道狭窄并接受 Optilume® 球囊治疗的患者。按照标准做法,在术前、术后 3 个月、6 个月和 12 个月通过流量计、问卷调查(PROM 和 IPSS)和膀胱镜检查收集数据。手术成功的定义是没有后续的尿道操作,Qmax > 10 ml/s。结果:2021 年 5 月至 2024 年 4 月期间,在西班牙 12 家医院接受 Optilume® 治疗的 238 名患者被纳入研究。对其中至少随访 3 个月的 156 名患者进行了分析。中位狭窄长度:1.5 厘米(0.5 - 5.3),主要位于球部尿道(87.7%)。其中,12.8%的患者曾接受过盆腔放疗,81.4%的患者曾接受过尿道操作。据报告,14.2%的患者出现了术后并发症。治疗成功率为 73.8%,中位随访时间为 8 个月(5-12 个月)。没有发现狭窄复发的预测因素。位于后尿道的狭窄复发率高于前尿道(42.9% 对 24.6%,P = 0.126)。结论:使用 Optilume® 治疗尿道狭窄的效果良好:结论:在短期常规临床实践中,使用 Optilume® 治疗已被证明是安全有效的。
{"title":"Efficacy and safety of Optilume® paclitaxel-coated urethral dilatation balloon in real-life: experience in a Spanish multicenter study","authors":"C. Ballesteros Ruiz ,&nbsp;F. Campos-Juanatey ,&nbsp;I. Povo Martín ,&nbsp;S. Mitjana Biosca ,&nbsp;Ó. Gorría Cardesa ,&nbsp;J.F. Aguilar Guevara ,&nbsp;N. García Formoso ,&nbsp;E. Fernández Pascual ,&nbsp;J.I. Martínez Salamanca ,&nbsp;S. Martínez Pérez ,&nbsp;J.M. Alonso Dorrego ,&nbsp;E. Ríos González ,&nbsp;S. San Cayetano Talegón ,&nbsp;A.M. Araujo Suarez ,&nbsp;E. Moran Pascual ,&nbsp;M.Á. Bonillo García ,&nbsp;J. Medina Polo ,&nbsp;L. Viver Clotet ,&nbsp;A.J. Vicens Morton ,&nbsp;J. Arce Gil ,&nbsp;L. Martínez-Piñeiro Lorenzo","doi":"10.1016/j.acuroe.2024.10.003","DOIUrl":"10.1016/j.acuroe.2024.10.003","url":null,"abstract":"<div><h3>Introduction</h3><div>The Optilume® Paclitaxel-coated urethral dilatation balloon is an alternative to conventional endoscopic treatments that combines mechanical dilatation with local delivery of paclitaxel.</div></div><div><h3>Objective</h3><div>To describe the success rate and analyze the safety of the device in real clinical practice. To evaluate possible predictors of treatment failure.</div></div><div><h3>Materials and methods</h3><div>Retrospective multicenter study in patients diagnosed with urethral stricture and treated with an Optilume® balloon in routine clinical practice. Data were collected from flowmetry, questionnaires (PROM and IPSS) and cystoscopy before surgery, and 3, 6 and 12 months after the procedure, according to standard practice. Surgical success was defined as the absence of subsequent urethral manipulation and a Qmax &gt;10 ml/s.</div></div><div><h3>Results</h3><div>238 patients treated with Optilume® in 12 Spanish hospitals between May 2021 and April 2024 were included in the study. Of these, 156 who had a minimum follow-up of 3 months, were analyzed. Median stricture length: 1.5 cm (0.5–5.3), mainly in bulbar urethra (87.7%). Of the total, 12.8% of patients had a history of pelvic radiotherapy, and 81.4% had undergone prior urethral manipulation. Postoperative complications were reported in 14.2% of the total. The treatment success rate was 73.8%, with a median follow-up of 8 months (5–12). No predictors of stricture recurrence were identified. Recurrence rates were higher in strictures located in the posterior versus anterior urethra (42.9% vs. 24.6%, p = 0.126). No significant differences were observed between patients with and without prior urethral manipulation.</div></div><div><h3>Conclusion</h3><div>Treatment with Optilume® has been shown to be safe and effective in short-term routine clinical practice.</div></div>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":"49 1","pages":"Pages 80-85"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Actas urologicas espanolas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1